Ercros has started up the second expansion of the Vila-seca I chlorine plant
Barcelona - Ercros has started a second expansion capacity of 26,000 t/year at the chlorine and caustic soda production plant of its factory in Vila-seca I, in accordance with the investment plan announced by the company.
At present, Ercros is undertaking a third expansion, also of 26,000 t/year, which it expected to be operational by mid-2019. Following this expansion, Ercros' global chlorine production capacity will be 217,000 t/year and will consolidate its leading position in the Iberian market.
The purpose of all these actions is to restore the real Ercros’ chlorine and caustic soda production to the level the company had before the cessation of mercury technology on December 11, 2017, following the European ban on the use of mercury in electrolytic plants. Currently, all the chlorine and caustic soda in Ercros is manufactured using membrane technology, which is considered the best available technology (BAT).
Categories
Investments
2018-03-05
at Chemmed Cluster Tarragona (ES)Chemical substances
Countries
Companies
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
